The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations
Open accessAbstract
Speech represents a promising novel biomarker by providing a window into brain health, as shown by its disruption in various neurological and psychiatric diseases. As with many novel digital biomarkers, however, rigorous evaluation is currently lacking and is required for these measures to be used effectively and safely. This paper outlines and provides examples from the literature of evaluation steps for speech-based digital biomarkers, based on the recent V3 framework (Goldsack et al., 2020). The V3 framework describes 3 components of evaluation for digital biomarkers: verification, analytical validation, and clinical validation. Verification includes assessing the quality of speech recordings and comparing the effects of hardware and recording conditions on the integrity of the recordings. Analytical validation includes checking the accuracy and reliability of data processing and computed measures, including understanding test-retest reliability, demographic variability, and comparing measures to reference standards. Clinical validity involves verifying the correspondence of a measure to clinical outcomes which can include diagnosis, disease progression, or response to treatment. For each of these sections, we provide recommendations for the types of evaluation necessary for speech-based biomarkers and review published examples. The examples in this paper focus on speech-based biomarkers, but they can be used as a template for digital biomarker development more generally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062
Linguistic Features Identify Alzheimer’s Disease in Narrative Speech
Fraser, K. C., Meltzer, J. A., & Rudzicz, F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150520 · Cited by 797
Self-citationSnowdon, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530310034029 · Cited by 696
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476
Mundt, J. C., Snyder, P. J., Cannizzaro, M. S., Chappie, K., & Geralts, D. S. (2007) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2006.04.001 · Cited by 380
Connected Speech in Neurodegenerative Language Disorders: A Review
Boschi, V., Catricalà, E., Consonni, M., Chesi, C., Moro, A., & Cappa, S. F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00269 · Cited by 362
Developing and adopting safe and effective digital biomarkers to improve patient outcomes
Coravos, A., Khozin, S., & Mandl, K. D. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0090-4 · Cited by 361
Riley, K. P., Snowdon, D. A., Desrosiers, M. F., & Markesbery, W. R. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.019 · Cited by 303
Toth, L., Hoffmann, I., Gosztolya, G., Vincze, V., Szatloczki, G., Banreti, Z., Pakaski, M., & Kalman, J. (2018) · Current Alzheimer Research · doi:10.2174/1567205014666171121114930 · Cited by 290
Speech Graphs Provide a Quantitative Measure of Thought Disorder in Psychosis
Mota, N. B., Vasconcelos, N. A. P., Lemos, N., Pieretti, A. C., Kinouchi, O., Cecchi, G. A., Copelli, M., & Ribeiro, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034928 · Cited by 265
Forbes-McKay, K. E., & Venneri, A. (2005) · Neurological Sciences · doi:10.1007/s10072-005-0467-9 · Cited by 261
Szatloczki, G., Hoffmann, I., Vincze, V., Kalman, J., & Pakaski, M. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00195 · Cited by 249
Automated classification of primary progressive aphasia subtypes from narrative speech transcripts
Fraser, K. C., Meltzer, J. A., Graham, N. L., Leonard, C., Hirst, G., Black, S. E., & Rochon, E. (2014) · Cortex · doi:10.1016/j.cortex.2012.12.006 · Cited by 229 · cited 1×
“Additionally, speech analysis has been shown to be able to detect individuals with depression [42–45], schizophrenia [46–49], autism spectrum disorder [50], and Parkinson’s disease [51, 52], and can differentiate the subtypes of primary progressive aphasia and frontotemporal dementia [53–55].”
BackgroundAided diagnosis of dementia type through computer-based analysis of spontaneous speech
Jarrold, W., Peintner, B., Wilkins, D., Vergryi, D., Richey, C., Gorno-Tempini, M. L., & Ogar, J. (2014) · Proceedings of the Workshop on Computational Linguistics and Clinical Psychology: From Linguistic Signal to Clinical Reality · doi:10.3115/v1/w14-3204 · Cited by 178
Mota, N. B., Copelli, M., & Ribeiro, S. (2017) · npj Schizophrenia · doi:10.1038/s41537-017-0019-3 · Cited by 157
Alzheimer's disease and automatic speech analysis: A review
Pulido, M. L. B., Hernández, J. B. A., Ballester, M. Á. F., González, C. M. T., Mekyska, J., & Smékal, Z. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2020.113213 · Cited by 120
Konig, A., Satt, A., Sorin, A., Hoory, R., Derreumaux, A., David, R., & Robert, P. H. (2018) · Current Alzheimer Research · doi:10.2174/1567205014666170829111942 · Cited by 119
Acoustic differences between healthy and depressed people: a cross-situation study
Wang, J., Zhang, L., Liu, T., Pan, W., Hu, B., & Zhu, T. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2300-7 · Cited by 98
Poole, M. L., Brodtmann, A., Darby, D., & Vogel, A. P. (2017) · Journal of Speech, Language, and Hearing Research · doi:10.1044/2016_jslhr-s-16-0140 · Cited by 84
Vogel, A. P., Rosen, K. M., Morgan, A. T., & Reilly, S. (2014) · Folia Phoniatrica et Logopaedica · doi:10.1159/000368227 · Cited by 44 · cited 2×
“While several studies found that smart-phones yield recordings of acceptable quality compared to standard microphones [20, 22, 24], others reported mixed findings with the differences relating to the particular audio outcome measures used [19, 21, 23].”
BackgroundResultAutomated Speech Recognition in Adult Stroke Survivors: Comparing Human and Computer Transcriptions
Jacks, A., Haley, K. L., Bishop, G., & Harmon, T. G. (2019) · Folia Phoniatrica et Logopaedica · doi:10.1159/000499156 · Cited by 30
Cited by
AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring
Wasilewski, T., Kamysz, W., & Gębicki, J. (2024) · Biosensors · doi:10.3390/bios14070356 · Cited by 290
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
Winchester, L. M., Harshfield, E. L., Shi, L., Badhwar, A., Khleifat, A. A., Clarke, N., Dehsarvi, A., Lengyel, I., Lourida, I., Madan, C. R., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13390 · Cited by 130
Hecker, P., Steckhan, N., Eyben, F., Schuller, B. W., & Arnrich, B. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.842301 · Cited by 78
Speech as a Biomarker: Opportunities, Interpretability, and Challenges
Ramanarayanan, V., Lammert, A. C., Rowe, H. P., Quatieri, T. F., & Green, J. R. (2022) · Perspectives of the ASHA Special Interest Groups · doi:10.1044/2021_persp-21-00174 · Cited by 70
Berisha, V., & Liss, J. M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01199-1 · Cited by 41
Metadata
- Authors
- Robin, J., Harrison, J. E., Kaufman, L. D., Rudzicz, F., Simpson, W., & Yancheva, M.
- Venue
- Digital Biomarkers
- Publisher
- S. Karger AG
- Published
- 2020-10-19
- Volume
- 4
- Issue
- 3
- Pages
- 99-108
- ISSN
- 2504-110X (ISSN-L)
- OpenAlex
- W3108822321
- Cited by
- 171
- References
- 22
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.